Last reviewed · How we verify

NCT05013541

Effect of Bladder Filling on Rectal Contractions During Cystometry

Completed Last updated 18 February 2022
What this trial tests

trial testing No intervention in Bladder Dysfunction in 50 participants. Completed in 30 September 2021.

Timeline
10 March 2021
Primary endpoint
31 August 2021
30 September 2021

Quick facts

Lead sponsorGérard Amarenco
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date10 March 2021
Primary completion31 August 2021
Estimated completion30 September 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Gérard Amarenco

Who can join

18 and older, any sex, with Bladder Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Increasing knowledge on rectal motility and bladder-rectum cross-talk has been published in recent years. However, whether bladder filling factors during multichannel urodynamic studies affect rectal contraction (RC) parameters has not been studied. The primary aim of this study is to assess the impact of bladder filling and desire to void on rectal contraction amplitude or frequency. Secondary objectives are to determine any significant change in rectal parameters depending on clinical and urodynamic factors or treatment. All patients referred for urodynamic assessment and with studies positive for rectal contractions as defined by the international continence society (ICS) will be included. Abdominal pressure will be measured using a T-doc air charged abdominal catheter inserted 10 cm from the anal margin. Standardized urodynamic evaluation will be conducted following ICS guidelines. Mean amplitude, maximal amplitude (cmH20) and mean frequency of rectal contractions on all urodynamic studies will be visually measured on the recording software and compared depending on bladder sensation (First Desire to void (FDV), Strong Desire to Void (SDV) and filling volume (200ml, 400ml). Demographic data (age, sex, BMI), underlying neurological disease, clinical symptoms, and scores (Neurogenic Bladder Symptom Score, Bristol Score, Cleveland Score), urodynamic parameters and treatments will be collected. Time since last defecation and meal will also be collected. This prospective observational study will be conducted in a Neuro-Urology department of a French university hospital. All the patients included are referred for multichannel urodynamic assessment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Bladder Dysfunction

Currently open trials in the same condition.

Other Gérard Amarenco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05013541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing